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Abstract
Background: Pregnancy is associated with increases in fasting triglycerides and total cholesterol.1 ApoE isoforms are known to 
influence the concentration of  cholesterol, with apoE2 homozygosity lowering and apoE4 homozygosity raising the cholesterol 
concentration compared with E3 homozygosity.2 The lipid profiles ApoE status and prevalence of  small dense LDL species 
were evaluated for subjects attending an antenatal clinic.
Results: Samples from 690 women aged between 16 and 42 years of  age were analyzed during and after pregnancy. The fasting 
plasma triglyceride concentration (in mmol/L) was significantly higher in pregnancy (median = 1.5, IQR 1.0-2.0 vs median = 0.6, 
IQR 0.5-0.8 respectively, p < 0.0001). Similarly, the total cholesterol (in mmol/L) was increased during pregnancy (median=4.1, 
IQR 3.6-4.7 vs median 3.5, IQR 3.1-3.5, respectively p=0.0167). The median LDL cholesterol and HDL cholesterol did not 
change. Higher proportions of  small density LDL species were seen during pregnancy compared to after pregnancy. The dis-
tribution of  the LDL species during pregnancy and 6 weeks post-partum were significantly different p<0.0001 with the smaller 
species being much higher during pregnancy.
Conclusion: ApoE4 genotype was associated with increased total cholesterol and LDL cholesterol concentrations during preg-
nancy. Pregnancy results in a reversible remodeling of  LDL to smaller species, the significance of  which is unknown but may 
indicate a predisposition to atherosclerosis
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Introduction
The increased metabolic demands for the mother and 
foetus during pregnancy results in the overproduction 
of  very low density lipoprotein cholesterol (VLDLC) by 
the liver as reflected by hypertriglyceridaemia and con-
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sequently the remodeling of  LDL to smaller, denser 
particles.3-5  When there is a hindrance of  clearance of  
remnants of  the triglycerides (TG)-rich lipoproteins or 
of  lipolysis by genetic defects in apoE and lipoprotein 
lipase (LPL), dyslipidaemia and severe hypertriglyceri-
daemia may occur during pregnancy. Apolipoprotein E 
(ApoE) facilitates the binding of  lipoprotein particles to 
the LDL receptor and heparane sulphate and proteogly-
cans6 and the ε4 allele has been associated with increased 
total cholesterol and consequent high risk for ischaemic 
heart disease in men.7-9 Similar changes can be expected 
in women. However, the prevalence of  ApoE alleles has 
been reported to vary in different populations10 but this 
genetic feature is not expected to be altered by pregnancy 
(See table 1). 
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In addition, there is a paucity of  evidence on the effect 
of  Apo E genotype on cholesterol subfractions during 
pregnancy.
While a high TG concentration has been associated with 
an increased risk of  coronary heart disease11,12, the gesta-
tional increase in TG is also associated with changes in 
the size  of  low density lipoproteins (LDL), with a grad-
ual increase in the proportion of  the smaller, denser spe-
cies.3,12 The smaller dense LDL species have been found 
to be atherogenic,13 possibly through their contribution to 
endothelial dysfunction as they are more easily oxidized 
14,15 and are less easily recognized by the LDL receptor, 
thereby staying in the plasma compartment longer.12  An-
other feature of  the small dense LDL species that adds 
to their high atherogenicity is that they are more readily 
taken up by macrophages, creating foam cells.12,14 
Most pregnant mothers display the physiologic TG in-
creases during pregnancy which is probably not athero-
genic given that there is  compensation  by an equal in-
crease in high density lipoprotein (HDL) which3,16 could 
provide benefit by  reverse cholesterol transport17,18 anti-
oxidant properties,18 anti-inflammatory properties19 and 
anti-aggregatory effects on platelets.20 However, preg-
nancy may precipitate significant hypertriglyceridaemia in 
susceptible individuals. This may be a risk for those with 
multiple pregnancies..
In this study we investigated the prevalence of  dyslipi-
daemia as well as the distribution of  the small dense LDL 
species in pregnant women with different ApoE geno-
types. We hypothesized that carriers of  the ApoE4 gen-
otype were more likely to have: 1) dyslipidaemia and 2) 
higher proportions of  the small dense LDL species
Materials and methods
Design and Setting
This cross-sectional study, performed between January 
2002 and December 2002 involved normal normotensive 
pregnant (diagnosed via clinical and ultrasound findings) 
women of  age 16-45 years. The women were recruited 
from two busy primary health care centres (Mbare and 
Mabvuku Polyclinics in Harare) during their scheduled 
antenatal appointments. All women who were able to 
consent and participate during and after pregnancy were 
included in the study provided they were not diabetic be-
fore or during pregnancy. Women with known complicat-
ed pregnancies were referred to tertiary care centres and 
not included in the study. In addition, women on lipid 
lowering drugs were excluded.
Sample collection, lipid measurements and APOE 
genotyping
Fasting venous blood samples were taken 2 times during 
pregnancy and 6 weeks after pregnancy. The blood sam-
ples were collected in 5ml EDTA (dipotassium ethylene-
diaminetetraacetic acid) containing tubes, centrifuged and 
the blood and serum were separated and stored frozen at 
minus 40 °C until assayed. Direct conventional enzymatic 
spectrophotometric methods, using the Roche Modular 
Auto-analyser, were employed to derive plasma triglyc-
eride (TG), total cholesterol (TC)and high-density lipo-
protein cholesterol concentrations (HDLC) while LDL 
cholesterol was calculated using the Friedewald formula. 
Genotyping of  apolipoprotein E (ApoE), using the buffy 
coat, was done by polymerase chain reaction as published 
by Hixson and Vernier,21 using the forward primer 5’- 
GAGACGCGGGCACGGCTGTC-3’ and the reverse 
primer 5’-GGGCCCCGGCCTGGTACACT-3’.
LDL species measurement
Non-denaturing gradient gel electrophoresis, using a Bio-
rad was employed to classify LDL species into 5 catego-
ries named A, AI, I, IB and B in decreasing sizes. Briefly, 
after thawing overnight, pre-stained (using Sudan Black 
Stain) lipoproteins in plasma were run at 4°C in a non-
denaturing gradient 3-8% gel sandwiched between 2 
glass plates. The lipoproteins were separated according 
to size in a gel in which the concentration of  acrylamide 
increased progressively. The gel was designed to separate 
all ApoB-containing lipoproteins. The small particles like 
LDL-B migrated furthest in the gel because the sizes of  
pores decrease with an increase in acrylamide content. 
The gels were removed at the end of  the run and excess 
fluid/buffer was blotted from the glass slides and the gels 
were photocopied onto a white paper for reporting and 
record keeping. Direct gel interpretation was made by 
blinded Lipidologists.
The gel terminology was derived to describe the lipopro-
teins corresponding to the particles separated and cali-
brated by ultracentrifugation. The origin of  the separa-
tion gel represents 0 and the migration of  small dense 
represents 1,0 and all lipoproteins in this gel system were 
calibrated by ultra-centrifugally prepared samples. Chy-
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lomicrons appear at the origin, Rf  0 - 0.15 termed as O. 
LDL 1 appeared between – and 0.15 and was referred to 
as Me while LDL2 was between - and -, referred to as MI. 
IDL was between Rf  0-085 and in this system included 
Lp(a). This range was called pre A. The LDL traction 
ranged from Rf  0.85- 1.0 displaying for most subjects a 
single or highly dominant discrete band. The largest was 
designated “A” and the smallest “B”. An “I” species was 
identified in the middle and further categories of  “AI” 
and “M” were also identified.
Statistical data analysis
All continuous data was tested for Normality using Shap-
iro Wilks test, with significance set at  p <0.05. LDL spe-
cies prevalence during pregnancy and was compared to 
that after pregnancy using chi squared and Fisher’s exact 
tests.  Lipid concentrations during and after pregnancy 
were compared using t-tests and their non-parametric 
equivalents as appropriate. Chi squared test was used to 
compare LDL species frequencies and proportions be-
tween the ApoE genotypes, whose frequencies were de-
termined by gene counting. The differences in the LDL 
species and lipid profiles among the ApoE genotypes 
were compared using the Kruskal Wallis test. For all sta-
tistical analysis, level of  significance was set at p<0.05.
Ethical Considerations
Ethical approval for the study was sought from and 
granted by the University of  Cape Town Human Ethics 
Research Committee and the Medical Research Council 
(MRC) of  Zimbabwe. All participants signed a written 
informed consent before taking part in the study.
Results
A total of  690 women were recruited during the period 
January 2002 to December 2002. Due to loss to follow-
up, only 472 who had data available during and after 
pregnancy were included in the final analysis. The median 
age of  the participating women was 24 years (IQR 20 – 
28 years), the youngest being 16 and the oldest being 42 
years of  age. The median gestational age at the time of  
collection of  the first sample (during pregnancy) was 29 
weeks (IQR 27 – 32 weeks): the earliest being 13 weeks 
and the latest being 38 weeks.
Table 1: Comparison of apoE genotype and allele frequency between pygmies and Africans 
 
Genotype Pygmies Africans 
ApoE2/2 0 2.3 
ApoE2/3 7.2 14.3 
ApoE2/4 4.3 4.3 
ApoE3/3 27.1 52.1 
ApoE3/4 45.7 22.8 
ApoE4/4 15.7 4.3 
Allele     
Apoԑ2 5.7 11.6 
    Apoԑ3 53.6 70.6 
Apoԑ4 40.7 17.8 
                          
                        Zekraoui et al 1997. Table 1 shows that apoε3 is the most predominant  
                        allele in the two groups, but apoε4 is very high in the pygmies 
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Prevalence of  LDL species during and after preg-
nancy
Table 2 below shows the distribution of  LDL species as 
measured during pregnancy and 6 weeks after pregnancy. 
During pregnancy, 38 (8%) of  the participants had no 
clearly definable LDL species, while 14 (3%) had 2 spe-
cies of  LDL and the remainder had a single species. After 
pregnancy dual species were seen in 9 (2%) while only 1 
participant had no clearly defined species.
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There were higher proportions of  the small dense LDL 
species during pregnancy than 6 weeks after pregnancy. 
During pregnancy distribution in the categories A, AI, I, 
IB, B was 2, 9, 34, 45, 10 % respectively while after preg-
nancy the LDL species distribution was: 44, 26, 26, 3 and 
1% respectively, p<0.0001.
 
Table 2: Prevalence of LDL species during and after pregnancy (n=472) 
 
  A AI I IB B Dual Species not 
clearly defined 
During 
pregnancy, n (%) 





120 (25.4) 120 (25.4) 15 (3.2) 4 (0.9) 9 (1.9) 1 (0.2) 
         
          CONTINGENCY TABLE CHI SQUARED P < 0.001 
ApoE genotypes prevalence and LDL species
Of  the 690 subjects, 678 participants had genotype data 
available which revealed that the majority were ApoE 
3/3, 271 (40%) followed by ApoE3/4, 175 (25.8%), 
ApoE2/3, 118 (17.4%), ApoE2/4, 48 (7%), ApoE4/4, 
41 (6.1%) and ApoE2/2, 25 (3.7%). ApoE genotype did 
not influence LDL species distribution during pregnancy 
(A vs I vs B, chi squared p-value = 0.33) or after preg-
nancy (A vs I vs B, chi squared p-value = 0.33).
The lipid profile changes in pregnancy and ApoE 
genotype
Table 3 below shows the comparison between plasma 
lipid median concentrations during and after pregnancy 
in the whole cohort. The median plasma triglyceride con-
centration (in mmol/L) was significantly higher in preg-
nancy, compared to concentration 6 weeks after pregnan-
cy (median = 1.5. IQR 1.0 - 2.1 vs. median = 0.6.IQR 
0.5 - 0.8 respectively, p < 0.0001). The median TC was 
significantly higher during pregnancy, compared to the 
TC 6 weeks after pregnancy (median = 4.1.IQR 3.6 -4.7 
vs median 3.6.IQR 3.1 - 4.0, respectively p<0.0001).
The median LDL cholesterol concentration during and 
after pregnancy did not change significantly (Table 3). 
Similarly no significant differences in median HDL cho-
lesterol during and after pregnancy were observed (Table 
3).
Table 3: Comparison of lipid changes during pregnancy and 6 weeks after pregnancy (n = 472) 
 
    TC TG LDLC HDLC 
During pregnancy Median (mmol/L) 4.1 1.5 2.0 1.3 
  IQR (mmol/L) 3.6 – 4.7 1.0 – 2.1 1.8 – 2.4 1.0 – 1.6 
After pregnancy* Median (mmol/L) 3.6 0.6 2.0 1.2 
  IQR (mmol/L) 3.1-4.0 0.5-0.8 1.6 – 2.0 0.9-1.4 
  Mann Whitney p - value <0.01 <0.001 0.16 0.167 
    
            * MEASURED AT LEAST 6 WEEKS AFTER DELIVERY 
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Table 4 shows the lipid concentrations according to the 
various ApoE genotypes during pregnancy. Median (TC) 
was higher in women with the ApoE4/4 genotype (me-
dian = 4.3, IQR 3.7-5.0) and ApoE3/3 (median = 4.2, 
IQR 3.5-4.7) compared to that of  women with ApoE2/2 
genotype (median = 3.5, IQR 3.3-4.5), p = 0.06. Median 
LDLC was higher in women with the ApoE 4/4 (median 
= 2.3, IQR 1.9-3.1), ApoE3/4 (median = 2.0, IQR 1.6-
2.6) and ApoE 3/3 (median = 2.0, IQR 1.6-2.6) when 
compared to the median LDLC concentration of  women 
with the ApoE2/2 genotype (median = 1.5, IQR 1.2-2.6), 
p = 0.02. 











































(n = 223) 
4.2 
(3.6-4.7) 
     1.4 
   (1.0-2.0) 
 
   2.0 
  (1.6-2.6) 
 
    1.2 
    (1.0-1.5) 
 
E4/4 
(n = 33) 
4.3 
(3.7-5.0)    1.4    (1.1-1.9) 
     2.3 
   (1.9-3.1) 
    1.2 





    0.846‡      0.021†      0.187π 
               
              COMPARISON BETWEEN E2/2 VS E3/3 VS E4/4 LIPID CONCENTRATIONS (USING KRUSKAL WALLIS)†P-VALUE FOR LDLC = 0.0196 
There were no significant differences between the ApoE 
genotypes in the concentrations of  triglycerides and high 
density lipoprotein cholesterol during pregnancy (Table 
4).
Discussion
There are many factors that determine the risk for the 
development of  cardiovascular disease. They include diet, 
smoking, hereditary factors, age and other comorbidi-
ties.16,22 The effect of  the ApoE gene polymorphisms on 
risk of  cardiovascular disease in normal pregnancies has 
not been investigated before in this African population. 
In addition, although the ApoE4 genotype has been asso-
ciated hypercholesterolaemia and thus with increased risk 
of  cardiovascular disease in studies from Western coun-
tries,16 its association with distribution of  the small dense 
LDL species during pregnancy is not well described.
We found that the distribution of  LDL species was not 
associated with ApoE genotype, during normal pregnan-
cy. Chikosi et al  demonstrated a fivefold higher preva-
lence of  ApoE2/2 and ApoE4/4 compared to that seen 
in other populations, although they found that this was 
not associated with the high levels of  dyslipidaemia in the 
Zulu women studied.23 However in this study, they did 
not measure lipid profiles of  the women.
The finding that the small dense LDL species are in-
creased during pregnancy is in agreement with previous 
findings in other ethnic groups and animal studies.3,24, 26 
Our data also shows that these small dense LDL species 
are likely physiologic and risk could be counterbalanced 
by HDL cholesterol increases.
In our study ApoE4 genotype was associated with in-
creased total cholesterol in normal pregnancy. This result 
agrees with a study in the Limpopo province of  South 
Africa that reported an association between ApoE4 allele 
with increased total cholesterol, LDLC, HDLC and TG in 
a non-pregnant population.22 Our results differ in that we 
did not find a significant association between the ApoE4 
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allele and both HDLC and TG.Our results indicated that 
serum cholesterol was within normal parameters in spite 
of  highly increased proportions of  small dense LDL spe-
cies. This finding agrees with the suggestion, that measur-
ing serum apolipoprotein B, instead of  serum cholesterol 
would detect more patients at risk of  myocardial infarc-
tion.25 Apolipoprotein B is the main protein that makes up 
LDL. Furthermore apolipoprotein B concentration has 
been shown to be highly correlated with coronary heart 
disease events,27 so monitoring its concentration may also 
help in assessing treatment progress in susceptible moth-
ers; however its value has not been studied prospectively 
in relation its changes in pregnancy.   In line with previ-
ous studies,3-5 our results showed significant increases in 
TG levels during pregnancy. This change is transient as 
demonstrated by the decrease in TG concentrations af-
ter pregnancy. In addition, we found that ApoE genotype 
was not associated with changes in the concentrations of  
TG in normal pregnancy in this African population.
Finally we found that ApoE genotypes prevalence in the 
Shona population was comparable to that described in a 
Zulu cohort.23 This may be a reflection of  the similarities 
in the populations studied, in that they are both Africans 
in the same geographical region, Southern Africa. His-
torically, the Ndebele, descendants of  the Zulu migrated 
to the North and settled in Zimbabwe and there have 
been inter-marriages between Ndebele and Shona people. 
Conclusion
ApoE genotype in Zimbabwean women in this study 
does not appear to influence LDL size, although ApoE4 
genotype appears to be associated with increases in  cho-
lesterol and LDL, compared to other genotypes. Preg-
nancy is associated with increases in the concentrations 
of  TG, TC and HDL in our population, although LDL 
does not appear to vary. There is a higher prevalence of  
small dense LDL species during pregnancy which reverts 
back to normal in this population.
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